554 Pill — BROWN OVAL, 12mm — Sitagliptin

No photo available

Imprint	554
Colour	BROWN
Shape	OVAL
Size	12
Strength	ERTUGLIFLOZIN PIDOLATE 5 mg;SITAGLIPTIN PHOSPHATE 100 mg
Dosage form	Tablet, Film Coated
Manufacturer	Merck Sharp & Dohme Corp.
NDC	0006-5367
Schedule	—
Availability	Prescription only
Ingredients	ERTUGLIFLOZIN PIDOLATE[ERTUGLIFLOZIN];SITAGLIPTIN PHOSPHATE[SITAGLIPTIN]

What does this imprint mean?

The imprint "554" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Sitagliptin

Uses and warnings

Pancreatitis - "postmarketing reports of acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis"; Heart Failure - association observed with DPP-4 inhibitors in cardiovascular trials; Acute Renal Failure - "postmarketing reports of worsening renal function, including acute renal failure"; Hypoglycemia risk increased when combined with insulin or insulin secretagogues; Hypersensitivity Reactions including anaphylaxis, angioedema, Stevens-Johnson syndrome; Arthralgia - severe joint pain reported with DPP-4 inhibitors; Bullous Pemphigoid, a blistering condition requiring hospitalization.

"JANUVIA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus." Not for type 1 diabetes or patients with pancreatitis history.

Read the full drug profile →